Skip to main content

Table 4 Descriptive summary of baseline values of various lung function parameters as well as of differences in those variables between baseline values and values obtained 6 weeks respectively 6 months after radiochemotherapy (RT/CHT.); corresponding p-values were calculated by conducting paired t-tests assessing whether those differences deviate statistically significant from zero.

From: Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study

  Baseline 6 Weeks after RT/CHT vs Baseline 6 Months after RT/CHT vs Baseline
  Mean SD Mean Diff. SD p-value Mean Diff. SD p-value
FVC (L) 3.25 0.83 -0.01 0.55 1.00 -0.18 0.45 1.00
FEV1 (L) 2.16 0.70 -0.02 0.32 1.00 -0.14 0.28 0.72
FEV1/VC (%) 63.62 15.38 2.86 17.06 1.00 2.91 14.16 1.00
RV (L) 3.01 0.82 -0.30 0.47 0.16 -0.11 0.71 1.00
TLC (L) 6.25 1.22 -0.33 0.72 0.54 -0.29 0.71 1.00
RV/TLC (%) 47.91 7.76 -2.35 5.85 1.00 -0.42 7.19 1.00
KCO (ml/(min*mmHg*L)) 5.74 2.26 -0.34 1.49 1.00 0.08 2.32 1.00
Pao2 (mmHg) 62.89 6.40 2.61 6.24 1.00 0.27 6.53 1.00
Paco2 (mmHg) 39.12 2.71 -2.01 3.97 0.54 -1.47 3.70 1.00